NYLT
EW icon

New York Life Trust’s Edwards Lifesciences EW Stock Holding History

New York Life Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,748
Closed -$136K – 216
2015
Q2 		$136K Buy
5,748
+78
+1% +$1.76K 0.56% 56
2015
Q1 		$135K Sell
5,670
-396
-7% -$8.88K 0.54% 62
2014
Q4 		$129K Sell
6,066
-1,242
-17% -$25K 0.51% 70
2014
Q3 		$124K Buy
7,308
+3,246
+80% +$51.2K 0.51% 72
2014
Q2 		$58K Buy
+4,062
New +$55.1K 0.24% 141

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

New York Life Trust's EW Position: Q3 2015 in Review

New York Life Trust sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 5,748 shares — an estimated $136K sold.

New York Life Trust first reported a position in EW in Q2 2014 and held it in 5 quarters. The position peaked at $136K in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • New York Life Trust reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • New York Life Trust sold 5,748 Edwards Lifesciences shares in Q3 2015, an estimated $136K.
  • New York Life Trust first reported a position in Edwards Lifesciences in Q2 2014 and held it in 5 quarters.
  • New York Life Trust's Edwards Lifesciences position peaked at $136K in Q2 2015.
  • 569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on New York Life Trust's 13F filing for Q3 2015, filed 16 Nov 2015.